2 Articles by Shakila Meshkat
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.
Canadian journal of psychiatry. Revue canadienne de psychiatrie – March 25, 2025
Summary
A single dose of psilocybin combined with psychotherapy shows promise for individuals with treatment-resistant depression, regardless of whether they were on antidepressants or not. Both groups experienced significant improvements in depressive and anxiety symptoms, highlighting psilocybin's potential in treating mood disorders effectively.
Abstract
ObjectiveTo compare changes in depression, anxiety, and suicidality symptoms after a single 25 mg oral dose of psilocybin between treatment-resista...
Psychedelics and Suicide-Related Outcomes: A Systematic Review.
Journal of clinical medicine – February 20, 2025
Summary
Suicide is a leading cause of death globally, emphasizing the urgent need for effective treatments. Recent findings suggest that psychedelics like psilocybin and MDMA may significantly reduce suicidal thoughts in individuals with mood and psychiatric disorders. Studies indicate notable improvements in suicidal ideation, showcasing the potential of these therapies for enhancing mental health outcomes.
Abstract
Background/Objectives: Suicide accounts for 1.4% of global deaths, and the slow-acting nature of traditional treatments for suicide risk underscore...